Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects.
about
Psychostimulants and cognition: a continuum of behavioral and cognitive activationMemory and psychostimulants: modulation of Pavlovian fear conditioning by amphetamine in C57BL/6 mice.Amphetamine and extinction of cued fear.The Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients.The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.Changes in emotions related to medication used to treat ADHD. Part I: literature review.The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?Toward quality care in ADHD: defining the goals of treatment.Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis.SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration.Neuropharmacology of Attention-Deficit/Hyperactivity Disorder
P2860
Q22242285-C6DD2A45-B8E8-4700-A6F8-A7DA549C01AEQ30481086-1BC02674-A3B4-4EE3-95B9-961AB3E38F15Q33908155-7AA3DEE1-0935-44DE-A76B-A74687A58019Q35666033-E2C3755D-787C-41BF-AEF3-ABF98BFE1ADFQ36082025-F06ED4BB-7FC8-4D7E-82E8-78FC0DD6E198Q36446854-9E74C0E2-1421-4624-8F30-BF39D0CD49ADQ37793743-0C8EE1D1-F3E7-452E-ACA3-6BCC82142131Q37983613-CA646C1B-ADC3-4948-ACBF-6E96434C236FQ38082894-0DDDE7A8-3A2E-4040-80D9-76BD8C5C5EE5Q38563913-9FB95FFF-DB6B-42B9-91EB-CF690D0BDB96Q44079943-1C3CDFF0-6FBD-4EDF-BF27-80252FA11A7AQ44217111-6254E6F9-ADEE-4E81-9219-544BCF44FF1FQ57277979-83A351C1-1A86-4BD7-A5D3-F52D59B5C020
P2860
Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Placebo-controlled evaluation ...... fficacy rate and side effects.
@ast
Placebo-controlled evaluation ...... fficacy rate and side effects.
@en
type
label
Placebo-controlled evaluation ...... fficacy rate and side effects.
@ast
Placebo-controlled evaluation ...... fficacy rate and side effects.
@en
prefLabel
Placebo-controlled evaluation ...... fficacy rate and side effects.
@ast
Placebo-controlled evaluation ...... fficacy rate and side effects.
@en
P2093
P356
P1433
P1476
Placebo-controlled evaluation ...... fficacy rate and side effects.
@en
P2093
P356
10.1542/PEDS.107.1.E10
P407
P577
2001-01-01T00:00:00Z